tiprankstipranks
Trending News
More News >
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market

Compare Prelude Therapeutics (PRLD) vs. Competitors

Compare
171 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prelude Therapeutics
$2.45
$102.47M
-1.12
77.45%
Plus Therapeutics
$0.58
$51.34M
-0.15
-75.88%
3 Buy
0 Hold
0 Sell
Strong Buy
Repare Therapeutics
$2.58
$111.22M
-1.52
101.56%
1 Buy
1 Hold
0 Sell
Moderate Buy
PMV Pharmaceuticals
$1.13
$60.13M
-0.71
-17.52%
4 Buy
0 Hold
0 Sell
Strong Buy
Gain Therapeutics
$1.81
$69.62M
-2.83
-23.63%
4 Buy
0 Hold
0 Sell
Strong Buy
Immix Biopharma
$4.32
$248.89M
-5.98
128.16%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRLD
Prelude Therapeutics
1.81
0.59
48.36%
PSTV
Plus Therapeutics
0.29
-0.95
-76.85%
RPTX
Repare Therapeutics
2.58
1.34
108.06%
PMVP
PMV Pharmaceuticals
1.13
-0.22
-16.30%
GANX
Gain Therapeutics
1.81
-0.37
-16.97%
IMMX
Immix Biopharma
4.70
2.73
138.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts